Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy.
Nagaoki Y, Aikata H, Miyaki D, Murakami E, Hashimoto Y, Katamura Y, Azakami T, Kawaoka T, Takaki S, Hiramatsu A, Waki K, Imamura M, Kawakami Y, Takahashi S, Chayama K. Nagaoki Y, et al. Among authors: miyaki d. J Gastroenterol. 2011 Jun;46(6):799-808. doi: 10.1007/s00535-011-0384-z. Epub 2011 Mar 4. J Gastroenterol. 2011. PMID: 21373851
Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.
Miyaki D, Aikata H, Kan H, Fujino H, Urabe A, Masaki K, Fukuhara T, Kobayashi T, Naeshiro N, Nakahara T, Kawaoka T, Hiramatsu A, Takahashi S, Ishikawa M, Kakizawa H, Awai K, Chayama K. Miyaki D, et al. J Gastroenterol Hepatol. 2013 Dec;28(12):1834-41. doi: 10.1111/jgh.12311. J Gastroenterol Hepatol. 2013. PMID: 23808713
Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.
Fujino H, Imamura M, Nagaoki Y, Kawakami Y, Abe H, Hayes CN, Kan H, Fukuhara T, Kobayashi T, Masaki K, Ono A, Nakahara T, Honda Y, Naeshiro N, Urabe A, Yokoyama S, Miyaki D, Murakami E, Kawaoka T, Hiraga N, Tsuge M, Hiramatsu A, Hyogo H, Aikata H, Takahashi S, Miki D, Ochi H, Ohishi W, Chayama K; Hiroshima Liver Study Group. Fujino H, et al. Among authors: miyaki d. J Gastroenterol. 2014 Dec;49(12):1548-56. doi: 10.1007/s00535-013-0924-9. Epub 2013 Dec 21. J Gastroenterol. 2014. PMID: 24362944 Clinical Trial.
Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration.
Naeshiro N, Aikata H, Kakizawa H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Ohno A, Miyaki D, Kawaoka T, Tsuge M, Hiraga N, Hiramatsu A, Imamura M, Kawakami Y, Takahashi S, Awai K, Chayama K. Naeshiro N, et al. Among authors: miyaki d. J Gastroenterol Hepatol. 2014 May;29(5):1035-42. doi: 10.1111/jgh.12508. J Gastroenterol Hepatol. 2014. PMID: 24372807
Pilot study of stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Honda Y, Kimura T, Aikata H, Nakahara T, Naeshiro N, Tanaka M, Miyaki D, Nagaoki Y, Kawaoka T, Takaki S, Hiramatsu A, Waki K, Ishikawa M, Kakizawa H, Kenjo M, Awai K, Nagata Y, Chayama K. Honda Y, et al. Among authors: miyaki d. Hepatogastroenterology. 2014 Jan-Feb;61(129):31-6. Hepatogastroenterology. 2014. PMID: 24895789
Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of response evaluation criteria in solid tumors and tumor markers.
Miyaki D, Kawaoka T, Aikata H, Kan H, Fujino H, Fukuhara T, Kobayashi T, Naeshiro N, Honda Y, Tsuge M, Hiramatsu A, Imamura M, Hyogo H, Kawakami Y, Yoshimatsu R, Yamagami T, Awai K, Chayama K. Miyaki D, et al. J Gastroenterol Hepatol. 2015 Apr;30(4):726-32. doi: 10.1111/jgh.12821. J Gastroenterol Hepatol. 2015. PMID: 25311578
Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
Kawaoka T, Aikata H, Hyogo H, Morio R, Morio K, Hatooka M, Fukuhara T, Kobayashi T, Naeshiro N, Miyaki D, Hiramatsu A, Imamura M, Kawakami Y, Takahashi S, Waki K, Tsuji K, Kohno H, Kohno H, Moriya T, Chayama K. Kawaoka T, et al. Among authors: miyaki d. J Dig Dis. 2015 Sep;16(9):505-12. doi: 10.1111/1751-2980.12267. J Dig Dis. 2015. PMID: 26121102
Multicentric hepatocarcinogenesis at 6 and 13 years after sustained viral response to hepatitis C virus.
Hashimoto Y, Miyaki D, Murakami E, Nagaoki Y, Kimura Y, Takahiro A, Katamura Y, Kawaoka T, Takaki S, Tsuge M, Hiraga N, Hiramatsu A, Waki K, Imamura M, Aikata H, Takahashi S, Arihiro K, Ohdan H, Chayama K. Hashimoto Y, et al. Among authors: miyaki d. Clin J Gastroenterol. 2012 Jun;5(3):204-9. doi: 10.1007/s12328-012-0303-8. Epub 2012 May 13. Clin J Gastroenterol. 2012. PMID: 26182322
Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining region.
Kawaoka T, Aikata H, Miyaki D, Murakami E, Azakami T, Takaki S, Nagaoki Y, Hashimoto Y, Katamura Y, Hiramatsu A, Waki K, Hiraga N, Miki D, Tsuge M, Imamura M, Kawakami Y, Takahashi S, Ochi H, Tashiro H, Ohdan H, Chayama K. Kawaoka T, et al. Among authors: miyaki d. Hepatol Res. 2011 Nov;41(11):1126-31. doi: 10.1111/j.1872-034X.2011.00853.x. Hepatol Res. 2011. PMID: 22032680
Recent trend of clinical features in patients with hepatocellular carcinoma.
Nagaoki Y, Hyogo H, Aikata H, Tanaka M, Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S, Hiramatsu A, Waki K, Imamura M, Kawakami Y, Takahashi S, Chayama K. Nagaoki Y, et al. Among authors: miyaki d. Hepatol Res. 2012 Apr;42(4):368-75. doi: 10.1111/j.1872-034X.2011.00929.x. Epub 2011 Dec 13. Hepatol Res. 2012. PMID: 22151896
31 results